{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:04:46Z","timestamp":1792411486539,"version":"4.4.0"},"reference-count":21,"publisher":"American Society of Hematology","issue":"17","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Children and adults with sickle cell disease (SCD) have increases in morbidity and mortality with COVID-19 infections. The American Society of Hematology Research Collaborative Sickle Cell Disease Research Network performed a prospective COVID-19 vaccine study to assess antibody responses and analyze whether messenger RNA (mRNA) vaccination precipitated any adverse effects unique to individuals with SCD. Forty-one participants received 2 doses of the Pfizer-BioNTech vaccine and provided baseline blood samples before vaccination and 2\u00a0months after the initial vaccination for analysis of immunoglobulin G (IgG) reactivity against the receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 spike protein. Six-month IgG reactivity against the viral RBD was also available in 37 patients. Postvaccination reactogenicity was common and similar to the general population. There were no fevers that required inpatient admission. Vaso-occlusive pain within 2 to 3\u00a0days of first or second vaccination was reported by 5 participants (12%) including 4 (10%) who sought medical care. Twenty-seven participants (66%) were seropositive at baseline, and all 14 initially seronegative participants (34%) converted to seropositive after vaccination. Overall, mRNA vaccination had a good risk-benefit profile in individuals with SCD. This mRNA vaccine study also marks the first evaluation of vaccine safety and antibody response in very young children with SCD. This trial was registered at www.ClinicalTrials.gov as #NCT05139992.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013878","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T19:03:09Z","timestamp":1720724589000},"page":"4549-4553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study"],"prefix":"10.1182","volume":"8","author":[{"given":"Alan R.","family":"Anderson","sequence":"first","affiliation":[{"name":"1PRISMA Health Comprehensive Sickle Cell Disease Program, Division of Pediatric Hematology-Oncology, University of South Carolina School of Medicine, Greenville, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-1457","authenticated-orcid":false,"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[{"name":"3Children's Hospital at Montefiore, Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Brandow","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Section of Hematology\/Oncology\/Bone Marrow Transplantation, Medical College of Wisconsin and Children\u2019s Research Institute of Children\u2019s Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"5Benioff Children's Hospital Oakland, Department of Pediatrics, UCSF, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-0043","authenticated-orcid":false,"given":"Andrew","family":"Campbell","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-2536","authenticated-orcid":false,"given":"Patrick J.","family":"Leavey","sequence":"additional","affiliation":[{"name":"7Simmons Comprehensive Cancer Center, Children's Medical Center, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alecia","family":"Nero","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim F.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Field","sequence":"additional","affiliation":[{"name":"9Department of Medicine, Medical College of Wisconsin, Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Baer","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haideliza","family":"Soto-Calderon","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Vincent","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"11Department of Microbiology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-4163","authenticated-orcid":false,"given":"Jefferson J. S.","family":"Santos","sequence":"additional","affiliation":[{"name":"11Department of Microbiology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-7506","authenticated-orcid":false,"given":"Scott E.","family":"Hensley","sequence":"additional","affiliation":[{"name":"11Department of Microbiology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mortier","sequence":"additional","affiliation":[{"name":"12ASH Research Collaborative, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[{"name":"13Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[{"name":"14Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Abrams","sequence":"additional","affiliation":[{"name":"10Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"3","key":"2024091012503193600_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.76.3.392","article-title":"Developmental pattern of splenic dysfunction in sickle cell disorders","volume":"76","author":"Pearson","year":"1985","journal-title":"Pediatrics"},{"issue":"9","key":"2024091012503193600_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ajh.24438","article-title":"Alteration of lymphocyte phenotype and function in sickle cell anemia: implications for vaccine responses","volume":"91","author":"Balandya","year":"2016","journal-title":"Am J Hematol"},{"issue":"16","key":"2024091012503193600_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJM197304192881601","article-title":"An abnormality of the alternate pathway of complement activation in sickle-cell disease","volume":"288","author":"Johnston","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2024091012503193600_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12026-018-9010-y","article-title":"Immunological role of CD4(+)CD28(null) T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy","volume":"66","author":"ElAlfy","year":"2018","journal-title":"Immunol Res"},{"issue":"9","key":"2024091012503193600_bib5","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1182\/blood-2010-04-278747","article-title":"Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial","volume":"117","author":"Rogers","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2024091012503193600_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00043426-200210000-00010","article-title":"Diminished antibody response to hepatitis B immunization in children with sickle cell disease","volume":"24","author":"Hord","year":"2002","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2","key":"2024091012503193600_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI112824","article-title":"Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency","volume":"79","author":"Bjornson","year":"1987","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2024091012503193600_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1542\/peds.82.4.571","article-title":"Haemophilus influenzae type b immunization of children with sickle cell diseases","volume":"82","author":"Frank","year":"1988","journal-title":"Pediatrics"},{"issue":"10","key":"2024091012503193600_bib9","doi-asserted-by":"crossref","first-page":"e0223991","DOI":"10.1371\/journal.pone.0223991","article-title":"Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with sickle cell disease","volume":"14","author":"Nagant","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"2024091012503193600_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","article-title":"COVID-19 in individuals with sickle cell disease\/trait compared with other Black individuals","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"2024091012503193600_bib11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7326\/M21-1375","article-title":"Sickle cell disorders and severe COVID-19 outcomes: a cohort study","volume":"174","author":"Clift","year":"2021","journal-title":"Ann Intern Med"},{"issue":"49","key":"2024091012503193600_bib12","doi-asserted-by":"crossref","first-page":"eabd5709","DOI":"10.1126\/sciimmunol.abd5709","article-title":"SARS-CoV-2 seroprevalence among parturient women in Philadelphia","volume":"5","author":"Flannery","year":"2020","journal-title":"Sci Immunol"},{"issue":"58","key":"2024091012503193600_bib13","doi-asserted-by":"crossref","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"issue":"4","key":"2024091012503193600_bib14","doi-asserted-by":"crossref","first-page":"100603","DOI":"10.1016\/j.xcrm.2022.100603","article-title":"Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination","volume":"3","author":"Mantus","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"2024091012503193600_bib15","doi-asserted-by":"crossref","first-page":"21232","DOI":"10.1038\/s41598-022-25134-0","article-title":"Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex","volume":"12","author":"Korosec","year":"2022","journal-title":"Sci Rep"},{"key":"2024091012503193600_bib16","doi-asserted-by":"crossref","first-page":"108871","DOI":"10.1016\/j.clim.2021.108871","article-title":"Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors","volume":"232","author":"Barnes","year":"2021","journal-title":"Clin Immunol"},{"issue":"2","key":"2024091012503193600_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/vaccines10020151","article-title":"Immunogenicity of the BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 vaccines in patients with hemoglobinopathies","volume":"10","author":"Radhwi","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"2024091012503193600_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bjh.18899","article-title":"Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease","volume":"202","author":"Nakahara","year":"2023","journal-title":"Br J Haematol"},{"issue":"1","key":"2024091012503193600_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/16078454.2022.2085072","article-title":"COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis","volume":"27","author":"Friedman","year":"2022","journal-title":"Hematology"},{"issue":"4","key":"2024091012503193600_bib20","first-page":"937","article-title":"Immune response of adult sickle cell disease patients after COVID-19 vaccination: the experience of a Greek Center","volume":"11","author":"Varelas","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"2024091012503193600_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjh.18547","article-title":"Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease","volume":"200","author":"Joseph","year":"2023","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/17\/4549\/2241145\/blooda_adv-2024-013878-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/17\/4549\/2241145\/blooda_adv-2024-013878-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:51:03Z","timestamp":1725972663000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/17\/4549\/516946\/COVID-19-mRNA-vaccination-responses-in-individuals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013878","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}